233 related articles for article (PubMed ID: 19112551)
1. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Exp Cell Res; 2010 Jan; 316(2):286-95. PubMed ID: 19716818
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of induction of muscle protein loss by hyperglycaemia.
Russell ST; Rajani S; Dhadda RS; Tisdale MJ
Exp Cell Res; 2009 Jan; 315(1):16-25. PubMed ID: 18973755
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of activation of dsRNA-dependent protein kinase (PKR) in muscle atrophy.
Eley HL; Russell ST; Tisdale MJ
Cell Signal; 2010 May; 22(5):783-90. PubMed ID: 20074639
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
Russell ST; Eley H; Tisdale MJ
Cell Signal; 2007 Aug; 19(8):1797-806. PubMed ID: 17532611
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Eley HL; Russell ST; Tisdale MJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1409-16. PubMed ID: 18854427
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cancer cachexia.
Tisdale MJ
Physiol Rev; 2009 Apr; 89(2):381-410. PubMed ID: 19342610
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I).
Russell ST; Eley H; Tisdale MJ
Cell Signal; 2007 Jul; 19(7):1583-95. PubMed ID: 17376652
[TBL] [Abstract][Full Text] [Related]
12. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy.
Vazeille E; Codran A; Claustre A; Averous J; Listrat A; Béchet D; Taillandier D; Dardevet D; Attaix D; Combaret L
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1181-90. PubMed ID: 18812460
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
15. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
16. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
Chand A; Wyke SM; Tisdale MJ
Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
Smith HJ; Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
Mirza KA; Pereira SL; Voss AC; Tisdale MJ
Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
[TBL] [Abstract][Full Text] [Related]
19. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
Belizário JE; Lorite MJ; Tisdale MJ
Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
